No Data
No Data
No Data
Stocks that moved on the previous day part 2: Tokyo Electron Ltd. unsponsored adr, SoftBank Group, Birdman, etc.
Stock name <Code> 4th closing price => Day-on-day variation Advantest <6857> 6129 -514 Nvidia has dropped by nearly 10%. Tokyo Electron <8035> 22995 -2150 also sold in the main stocks of the semiconductor-related general decline. Hokkaido Electric Power <9509> 1014 -66.5 The decline in semiconductor stocks may have spread to datacenter-related stocks. Softbank G <9984> 7781 -652 follows the decline of the Nasdaq index. First
Active and newly listed stocks during the morning session.
*Fujisoft <9749> 9620 +650 Bain Capital submits acquisition proposal to counter KKR. *Bandai Namco HD <7832> 3219 +105 SBI Securities raises target stock price. *MonotaRO <3064> 2367 +63.5 yen high interest as a merit stock. *Nitori HD <9843> 22005 +5558 monthly trends and a reversal of yen appreciation are considered positive factors. *Sunwellz <9229> 2038 -378 rumored in some circles.
Stocks that hit the daily limit up or down in the morning session.
■Stock Limit Up <143A> Iishin <3841> Jidat <4888> Stella Pharma <5025> Mercury <5610> Yamato Heavy Industries <5616> Rain, Wind, Sun ■ Stock Limit Down ※Includes temporary stock limit up/down (quotation value)
Volume change rate ranking (9 o'clock) - Stella Pharma, Ito En, etc. are ranked.
※In the volume change rate ranking, you can understand the interest of market participants such as trends in market sentiment by comparing the average volume of the latest 5 days with the volume on the delivery day. ■ Top volume change rate [As of September 3, 9:32 AM] (Comparison with the average volume of the latest 5 days) Stock Code Stock Name Volume Average Volume Volume Change Rate Stock Price Change Rate <4263> Susmedo 1075600 107185.08 286.96% -0.04
Stella Pharma has entered the rankings, signing clinical trial contracts for boron neutron capture therapy with the National Cancer Center, etc.
Stella Pharma <4888> has entered the rankings as of 9:32 am. It is significantly higher. After the end of trading the previous day, it was announced that Stella Pharma has signed contracts with the National Cancer Center, Sumitomo Heavy <6302>, and CICS for the phase 1/2 basket trial of boron neutron capture therapy (NCT) for patients with inoperable and unresectable recurrent thoracic solid malignant tumors, which seems to have become a trigger for buying. The purpose is to evaluate the safety and efficacy of BNCT using boron agents.
Soft tone, lacking clues and difficult to determine direction.
[Emerging Markets Individual Stock Strategy] Today, emerging markets are expected to see a weak development. The U.S. stock market was closed on the 2nd for Labor Day. In European major markets, the UK's FTSETM100 fell by 0.15%, Germany's DAX rose by 0.13%, and France's CAC40 rose by 0.20%. It seems that selling will dominate the market in today's emerging markets. With the U.S. market closed yesterday and European major markets showing mixed movements with minor fluctuations, which makes it difficult to provide clues for the Tokyo market, the market is anticipating a rate cut by the U.S.
No Data
No Data